文献速递甲状腺疾病

小鼠慢性甲状腺功能亢进及三碘甲状腺原氨酸撤退期间肝脏TRβ蛋白表达、脂生成基因表达和长链酰基肉碱水平的变化

Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model.
PubMed 文献 · Thyroid · 2017-05-24

成年雄性小鼠每日注射T3(20 μg/100 g体重)14天后停用10天,在首次注射后6小时、24小时、14天及停药后10天取肝分析。慢性T3暴露后肝脏TRβ蛋白下降,停药后恢复至基线;停药后长链酰基肉碱水平反常升高,脂生成基因表达上调,尽管血清TSH和TH水平已正常化。

要点

  • 慢性T3处理使肝脏TRβ蛋白下降,停药后恢复至基线水平。
  • 停药后长链酰基肉碱水平反常升高,急性T3处理时曾见升高。
  • 停药后脂生成基因表达上调,乙酰辅酶A羧化酶磷酸化降低。

核心结论

  • 成年雄性野生型和Mct8敲除小鼠慢性T3暴露后肝脏TRβ蛋白表达下降。
  • 停药后尽管血清TSH和TH水平正常化,基因芯片通路和代谢组学分析分别显示肝脏脂生成基因表达和酰基肉碱水平异常。
  • 这些发现可能有助于解释部分甲状腺功能亢进及恢复期患者的临床表现差异,因为TRβ蛋白、靶基因表达和代谢适应变化可在个别组织发生而不一定反映在循环TH和TSH浓度上。

研究设计与样本

  • 成年雄性小鼠每日注射T3(20 μg/100 g体重)14天,随后停用T3 10天。
  • 在首次T3注射后6小时、24小时和14天,以及停药后10天取肝脏,进行定量逆转录聚合酶链反应、Western blotting和代谢组学分析。
  • 另在成年雄性Mct8敲除小鼠(慢性肝内甲状腺功能亢进的体内模型)中观察TRβ蛋白表达。

主要发现

  • 慢性T3处理后TH受体(TRα和TRβ)mRNA仅轻度下降,但仅TRβ蛋白下降,停药后恢复至基线表达水平。
  • 其他TH作用调节因子的表达未改变。
  • 成年雄性Mct8敲除小鼠中TRβ蛋白表达也下降。
  • 慢性T3处理后长链酰基肉碱水平未改变,停药后反而升高。
  • 既往微阵列结果的通路分析显示急性T3处理和停药后脂生成基因上调;停药后乙酰辅酶A羧化酶磷酸化也降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thyroid hormone (TH) has important roles in regulating hepatic metabolism. It was previously reported that most hepatic genes activated by a single triiodothyronine (T3) injection became desensitized after multiple injections, and that approximately 10% of target genes did not return to basal expression levels after T3 withdrawal, despite normalization of serum TH and thyrotropin (TSH) levels. To determine the possible mechanism(s) for desensitization and incomplete recovery of hepatic target gene transcription and their effects on metabolism, mRNA and/or protein expression levels of key regulators of TH action were measured, as well as metabolomic changes after chronic T3 treatment and withdrawal. METHODS: Adult male mice were treated with daily injections of T3 (20 μg/100 g body weight) for 14 days followed by the cessation of T3 for 10 days. Livers were harvested at 6 hours, 24 hours, and 14 days after the first T3 injection, and at 10 days after withdrawal, and then analyzed by quantitative reverse transcription polymerase chain reaction, Western blotting, and metabolomics. RESULTS: Although TH receptor (TRα and TRβ) mRNAs decreased slightly after chronic T3 treatment, only TRβ protein decreased before returning to basal expression level after withdrawal. The expression of other regulators of TH action was unchanged. TRβ protein expression was also decreased in adult male monocarboxylate transporter-8 (Mct8)-knockout mice, an in vivo model of chronic intrahepatic hyperthyroidism. Previously, increased hepatic long-chain acylcarnitine levels were found after acute TH treatment. However, in this study, long-chain acylcarnitine levels were unchanged after chronic T3, and paradoxically increased after T3 withdrawal. Pathway analyses of the previous microarray results showed upregulation of lipogenic genes after acute T3 treatment and withdrawal. Phosphorylation of acetyl-CoA carboxylase also decreased after T3 withdrawal. CONCLUSIONS: Decreased hepatic TRβ protein expression occurred after chronic T3 exposure in adult male wild-type and Mct8-knockout mice. Gene array pathway and metabolomics analyses showed abnormalities in hepatic lipogenic gene expression and acylcarnitine levels, respectively, after withdrawal, despite normalization of serum TSH and TH levels. These findings may help explain the variable clinical presentations of some patients during hyperthyroidism and recovery, since TRβ protein, target gene expression, and metabolic adaptive changes can occur in individual tissues without necessarily being reflected by circulating TH and TSH concentrations.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ohba K, Sinha RA, Singh BK, et al. Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model. Thyroid. 2017. PMID: 28457184. doi:10.1089/thy.2016.0456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。